Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Anguita

Showing results (71-80 of 266) with videos related to

Pageof 27
Sort By:
Medicina Clinica|November 21, 2023
Evidence of the association between increased use of direct oral anticoagulants and a reduction in the rate of atrial fibrillation-related stroke and major bleeding at the population level (2012-2019)Carlos Loucera, Rosario Carmona, Gerrit Bostelmann, et al.
Revista Espanola De Cardiologia (English Ed.)|March 4, 2017
Differences in the Characteristics and Management of Patients With Atrial Fibrillation Followed-up by Cardiologists and Other SpecialistsLucía Carnero Montoro, Inmaculada Roldán Rabadán, Francisco Marín Ortuño, et al.
Expert Review of Cardiovascular Therapy|August 14, 2009
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failureJavier Díez, Antonio Coca, Eduardo de Teresa, et al.
Revista Espanola De Cardiologia|November 19, 2003
[Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function. Do they differ in systolic dysfunction?]Soledad Ojeda, Manuel Anguita, Juan F Muñoz, et al.
Medicina Clinica|August 3, 2010
[Usefulness of brain natriuretic peptide levels, as compared with usual clinical control, for the treatment monitoring of patients with heart failure]Manuel Anguita, Fátima Esteban, Juan C Castillo, et al.
The Journal of Heart Valve Disease|February 17, 2006
Pacemaker-related endocarditis: clinical features and treatmentMartín Ruiz, Manuel Anguita, Juan C Castillo, et al.
Revista Espanola De Cardiologia (English Ed.)|October 13, 2022
Age and stabilization of admissions for heart failure in Spain (2006-2019). The beginning of the end of the "epidemic"?María Anguita Gámez, Alberto Esteban Fernández, María García Márquez, et al.
Geriatrics & Gerontology International|December 18, 2022
Clinical features and outcomes of acute heart failure in nonagenarians: Results of a nationwide studyMaría Anguita-Gámez, Alberto Esteban-Fernández, Náyade Del Prado, et al.
Revista Espanola De Cardiologia|July 15, 2011
[The Spanish Society of Cardiology and the ESC clinical practice guidelines: towards a new orientation]Manuel Anguita, Antonio Fernández-Ortiz, Fernando Worner, et al.
Journal of the American College of Cardiology|September 3, 2016
Quality Improvement Strategy of the Spanish Society of Cardiology: The RECALCAR RegistryLuis Rodríguez-Padial, Vicente Bertomeu, Francisco Javier Elola, et al.
Pageof 27

Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
Medicina Clinica|November 21, 2023
Evidence of the association between increased use of direct oral anticoagulants and a reduction in the rate of atrial fibrillation-related stroke and major bleeding at the population level (2012-2019)Carlos Loucera, Rosario Carmona, Gerrit Bostelmann, et al.
Revista Espanola De Cardiologia (English Ed.)|March 4, 2017
Differences in the Characteristics and Management of Patients With Atrial Fibrillation Followed-up by Cardiologists and Other SpecialistsLucía Carnero Montoro, Inmaculada Roldán Rabadán, Francisco Marín Ortuño, et al.
Expert Review of Cardiovascular Therapy|August 14, 2009
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failureJavier Díez, Antonio Coca, Eduardo de Teresa, et al.
Revista Espanola De Cardiologia|November 19, 2003
[Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function. Do they differ in systolic dysfunction?]Soledad Ojeda, Manuel Anguita, Juan F Muñoz, et al.
Medicina Clinica|August 3, 2010
[Usefulness of brain natriuretic peptide levels, as compared with usual clinical control, for the treatment monitoring of patients with heart failure]Manuel Anguita, Fátima Esteban, Juan C Castillo, et al.
The Journal of Heart Valve Disease|February 17, 2006
Pacemaker-related endocarditis: clinical features and treatmentMartín Ruiz, Manuel Anguita, Juan C Castillo, et al.
Revista Espanola De Cardiologia (English Ed.)|October 13, 2022
Age and stabilization of admissions for heart failure in Spain (2006-2019). The beginning of the end of the "epidemic"?María Anguita Gámez, Alberto Esteban Fernández, María García Márquez, et al.
Geriatrics & Gerontology International|December 18, 2022
Clinical features and outcomes of acute heart failure in nonagenarians: Results of a nationwide studyMaría Anguita-Gámez, Alberto Esteban-Fernández, Náyade Del Prado, et al.
Revista Espanola De Cardiologia|July 15, 2011
[The Spanish Society of Cardiology and the ESC clinical practice guidelines: towards a new orientation]Manuel Anguita, Antonio Fernández-Ortiz, Fernando Worner, et al.
Journal of the American College of Cardiology|September 3, 2016
Quality Improvement Strategy of the Spanish Society of Cardiology: The RECALCAR RegistryLuis Rodríguez-Padial, Vicente Bertomeu, Francisco Javier Elola, et al.
Pageof 27